The effects of zenarestat, an aldose reductase inhibitor, on minimal F-wave latency and nerve blood flow in streptozotocin-induced diabetic rats

Life Sciences

Volumn 68, Issue 12, 2001, Pages 1439-1448

  Yamamoto, Tadashi ^a   Takakura, Shoji ^a   Kawamura, Ikuo ^a   Seki, Jiro ^a   Goto, Toshio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Diabetic peripheral neuropathy; F wave minimal latency; Nerve blood flow; Polyol pathway; Zenarestat

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; GLUCOSE; STREPTOZOCIN; ZENARESTAT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; LATENT PERIOD; MALE; NERVE CELL EXCITABILITY; NONHUMAN; RAT; STREPTOZOCIN DIABETES; WAVEFORM;

ALDEHYDE REDUCTASE; ANIMALS; BLOOD FLOW VELOCITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENZYME INHIBITORS; MALE; NEURAL CONDUCTION; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SCIATIC NERVE; STREPTOZOCIN;

EID: 0035830586     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)00938-9     Document Type: Article

References (45)

1. Diabetic neuropathies
2. Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage
3. Complications: Neuropathy, pathogenetic considerations
4. The involvement of aldose reductase in diabetic complications
5. Pathology and pathogenetic mechanisms of diabetic neuropathy
6. Effect of 24 weeks of treatment with epal-restat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus
7. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats
8. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, NA/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats
9. Pharmacological inhibition of aldose reductase in human diabetic neuropathy
10. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy
11. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat
12. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy
13. Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits
14. Sural nerve oxygen tension in diabetes
15. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function
16. 1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235
17. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost
18. 1-adrenoceptor antagonist treatment: Interactions with the nitric oxide system
19. Effect of cilostazol on experimental diabetic neuropathy in the rat
20. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat
21. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism
22. Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats
23. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus
24. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: Multicentre analysis in healthy subjects and patients with diabetic polyneuropathy
25. Serial changes of sensory nerve conduction velocity and minimal F-wave latency in streptozotocin-induced diabetic rats
26. 1 on peripheral diabetic neuropathy in C57BL/Ksj-db/db mice
27. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
28. Distal tibial mononeuropathy in diabetic and non-diabetic rats reared on wire cages: An experimental entrapment neuropathy
29. Non-contact laser tissue blood flow measurement using polarization to reduce the specular reflection artefact
30. Separation and determination of phenyl isocyanate-derivatized carbohydrates and sugar alcohols by high-performance liquid chromatography with ultraviolet detection
31. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy
32. Analysis of F-wave in metabolic neuropathies: A comparative study in uremic and diabetic patients
33. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats
34. Measurement of coronary sinus blood flow by fiber-optic laser Doppler anemometry
35. Continuous measurement of intestinal mucosal blood flow by laser-Doppler velocimetry
36. Dynamic peripheral nerve metabolic and vascular responses to exsanguination
37. 14C]iodoantipyrine
38. Nerve ischaemia in diabetic rats: Time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models
39. Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: Effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil
40. Regional blood flow in resting and stimulated sciatic nerve of diabetic rats
41. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
42. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway
43. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats
44. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
45. 2) synthesis by aortic rings from rats with streptozotocin-induced diabetes